Gerald Gross, MD
Hematology & Oncology Physician in Fargo, North Dakota.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Gerald Gross, MD reported a CMS MIPS final score of 83/100 - below the 83.5 national average - and filed 410 Medicare Part D claims in 2024.
- 83/100
- MIPS score · -1 vs avg
- 410
- Part D claims, 2024
- 70%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Gerald Gross, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1013935667), first enumerated 07/18/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 410 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 83/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1013935667 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1013935667
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- MIPS-INLINE 83/100
- RX-LIGHT 410
- BOOK-THIN 30 in North Dakota
- PHOTO-FINISH Michael Lyster · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Gross · this pro…
Gross · this provider
83 MIPS pts
- Carlos Araujo · …
Carlos Araujo
83 MIPS pts
- Michael Lyster ·…
Michael Lyster
83 MIPS pts
- Shelby Terstriep…
Shelby Terstriep
83 MIPS pts
- William Taylor ·…
William Taylor
83 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Gerald Gross, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
83 ≥ 36th percentile 36% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Gerald Gross, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Gerald Gross, MD writes more Part D claims than 32% of them and scores higher on MIPS quality than 36% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Gerald Gross, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Gerald Gross, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Gerald Gross, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in North Dakota
How Hematology & Oncology Physician compares to other specialties among North Dakota providers
Hematology & Oncology Physician ranks #74 among North Dakota's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the North Dakota provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Gerald Gross, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 83/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Hematology & Oncology Physician US NPIs
83/100 MIPS final score - 0.5 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 87.1. Cost dim: 57.1.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1013935667 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Gerald Gross, MD's current license status, disciplinary history, and board certifications with the North Dakota Board of Medicine in North Dakota before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1013935667 is the unique 10-digit identifier CMS uses to link Gross across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 70% generic, on 410 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 621.967
- Total Day Supply
- 17,572
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $1.6M
- Generic Drug Cost
- $95K
- Antibiotic Claims
- 38
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 2.51
- Gender Split
- 55% female / 45% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Gerald Gross, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Valacyclovir
Valacyclovir
48 claims
- Hydroxyurea
Hydroxyurea
45 claims
- Eliquis
Eliquis
20 claims
- Brukinsa 19
Brukinsa
19 claims
- Imatinib Mesylate 19
Imatinib Mesylate
19 claims
- Imbruvica 19
Imbruvica
19 claims
- Sulfamethoxazole-T… 19
Sulfamethoxazole-Trimethoprim
19 claims
- Jakafi 18
Jakafi
18 claims
| Drug | Claims |
|---|---|
| Valacyclovir Valacyclovir Hcl | 48 |
| Hydroxyurea | 45 |
| Eliquis Apixaban | 20 |
| Brukinsa Zanubrutinib | 19 |
| Imatinib Mesylate | 19 |
| Imbruvica Ibrutinib | 19 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 |
| Jakafi Ruxolitinib Phosphate | 18 |
| Inrebic Fedratinib Dihydrochloride | 12 |
| Zolpidem Tartrate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Gerald Gross, MD fits within the Hematology & Oncology Physician landscape nationally.
Gerald Gross, MD's 410 claims are below the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gross, both outside North Dakota so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (83 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in North Dakota
Other clinicians with the same primary specialty enrolled in North Dakota, drawn from the same CMS NPPES roster as Gross.
One of 30 Hematology & Oncology Physician providers enrolled in North Dakota, 5 are shown here.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Gerald Gross, MD's specialty? ▼
How much does Gerald Gross, MD prescribe under Medicare Part D? ▼
What is Gerald Gross, MD's Medicare quality score? ▼
Where is Gerald Gross, MD located? ▼
What is Gerald Gross, MD's NPI number? ▼
Does Gerald Gross, MD prescribe more brand-name or generic drugs? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Gerald Gross, MD prescribe most often? ▼
Does Gerald Gross, MD accept Medicare? ▼
How can I verify Gerald Gross, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.